NewsRx

Search our medical news database

FDA Law Weekly

Susan Hasty, Publisher

Table of Contents . . . September 29th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in FDA Law Weekly | Other Publications

American Coll. for Advancement in Med. - Group defends use of EDTA therapy related to chelation therapy

Avax Technologies - IND filed for drug to treat patients with non-small-cell lung cancer

Barr Pharmaceuticals - FDA defers decision on Plan B over-the-counter application

Barr Pharmaceuticals - U.S. FDA grants approval for Allegra tablets

Baxter Healthcare Corp. - U.S. FDA grants approval for Ceftriaxone injection

Biogen Idec - Supplemental BLA submitted to U.S. FDA for Rituxan

Biosite - CLIA waiver granted for Triage BNP Test

Biotronik - Implantation of Lumos DR-T implantable cardioverter defibrillator announced

Bristol-Myers Squibb - Supplemental Biologics License Application filed for head, neck cancer treatment

C. Drew Univ. of Medicine & Science, Los Angeles - Nandrolone decanoate benefits HIV-infected men with weight loss

Cadence Pharmaceuticals - Phase III trial of CPI-226 initiated for catheter-related infections

Calypte Biomedical - Maryland facility approved for the manufacture of HIV-1 Urine EIA test

Caraco Pharmaceutical Laboratories - U.S. FDA grants tentative approval for Zolpidem Tartrate

CardioTech International - FDA clears heparin-coated auto transfusion and cardiotomy products

Cephalon - Agreement reached to promote Attenace for ADHD

A&G Pharmaceutical - Theranostics company completes series A financing

Accelerat BioPharmaceutical - Activation of antithrombin III increases its anti-HIV activity up to 1000-fold

Advaxis - Listeria cancer vaccine shows strong safety profile in toxicology studies

Allon Therapeutics - Compounds have potential to protect brain cells

Allon Therapeutics - Phase I trial begins for therapy for post-surgery mild cognitive impairment

Allos Therapeutics - Results from Efaproxyn study published in journal

Altachem Pharma - Oncology firm reconstitutes scientific advisory board

Altea Therapeutics - Steven P. Damon appointed to lead business development team at pharma firm

Antoni Van Leeuwenhoek Hospital, Amsterdam - Isolated limb perfusion palliated advanced limb disease

Archus Orthopedics - Clinical trial enrollment initiated for arthroplasty system

Argenta Discovery - Drug discovery collaboration signed with Cellzome

Bentley Pharmaceuticals - New president named at drug delivery-focused pharmaceutical firm

Biopure Corp. - Oxygen therapeutics company appoints Guido J. Neels to board of directors

Burnham Institute - Cancer drug target Chk1 may also be source of drug resistance

CHU Vaudois - Photodynamic therapy shows selectivity for mesothelioma

Candelaria Univ. Hospital, Santa Cruz de Tenerife -  Shigella sonnei outbreak in Canary Islands produced by a single strain

Centro Medico Nacional Siglo XXI, Mexico City - Hepatitis C infection remains stable despite therapy-induced neutropenia

Cerenis Therapeutics - HDL-focused company to develop new therapies based on PPAR delta agonists

Chaim Sheba Medical Center, Tel Hashomer - Researchers evaluate criteria for decisions on breast conservation therapy

Children's Hospital of Philadelphia - Children using community health centers more likely to be overweight

Children's Hospital, Boston - Study finds potentially better test for infant iron deficiency

Chiron Corp. - Company announces favorable results of FDA inspection of Fluvirin facility

Cleveland Clinic - Peptide for protein and vector neuronal targeting identified

Colorado State University - Rv3806c-encoded enzyme is a target for the development of new tuberculosis drugs

Cornell University, New York - Indinavir plus ritonavir increases AUCs of calcium channel blockers in HIV/AIDS

Cosmetic Surgery - Beachwood Laser Clinic offers Botox, Restylane treatments

Cyberonics - Data from D-02 study treated with vagus nerve stimulation published in journal

CytRx Corp. - RIP140 agonist advances into studies for treatment of obesity, type 2 diabetes

Dana Farber Cancer Institute, Boston - Neoadjuvant and concurrent hormonal therapy impacted acute GI toxicities

Daxor Corp. - Blood volume analyzer purchased by the Queens Medical Center in Honolulu, Hawaii

Decision Resources - Market for urge urinary incontinence is improved by patient-physician awareness

Dimethaid Research - Dimethaid Research, Inc. announces new pancreatic cancer trial with WF10

Edge Information - New research study examines clinical trial budgets, recruiting, productivity

Eisai Co. - Company submits sNDA to FDA for Aricept for treatment of severe AD

Emergent BioSolutions - Typhoid vaccine achieves positive results in phase II clinical study

European Institute of Oncology, Milan - Recent studies add new data to breast cancer research

European Society of Cardiology - Aspirin and Clopidogrel effective to treat ACS

European Society of Cardiology - Cost-effectiveness of drug-eluting stents compared with a bare-metal stent

GlaxoSmithKline - GlaxoSmithKline announces U.S. FDA approval of FLUARIX

Glenmark Pharmaceuticals - GRC 3886 molecule to be named Oglemilast; receives approval for further trials

McNeil Consumer & Specialty Pharmaceuticals - Pharma company entered agreement with Cephalon to copromote modafinil

Medtronic - FDA approves CardioSight Service

Migenix - Initiation of MX-226 phase III clinical study announced

Novartis - Femara granted FDA priority review for new indication: early breast cancer

Schering-Plough - FDA approves grape flavored version of Children's Claritin

Scripps Research Institute - Virus clearance from cells infected with arenavirus examined

Spectrum Pharmaceuticals - Spectrum Pharmaceuticals announces filing of twelfth ANDA with the U.S. FDA

Takeda Pharmaceuticals North America - U.S. FDA approves NDA for type 2 diabetes drug

U.S. Food & Drug Administration - Analysis of nitrogen mustard in topical drugs reported

U.S. Food & Drug Administration - Diagnostic criteria for monoclonal B-cell lymphocytosis outlined

U.S. Food & Drug Administration - Erythromycin affects microbial populations in aquaculture sediment

U.S. Food & Drug Administration - Susceptibility testing method for aquatic bacteria standardized

Uroplasty, Inc. - U.S. FDA grants clearance to sell female incontinence sling in U.S. market

VA Pittsburgh Healthcare System - Proactive approach can prevent nosocomial Legionnaires' disease

deCODE - U.S. NIH grant awarded to identify genetic factors related to nicotine addiction

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook